2019 Summary

Dear Members of the Neurotech Community,

Thank you very much for taking the time to participate in the Neurotech Investing and Partnering Conference in Boston this May! Over 150 participants united in Boston including attendees and 70 speakers and panelists on the cutting edge of researching, developing and funding the next generation of treatments for the brain and nervous system.

Neurotech continues to be the premier business and investment conference for commercial neuroscience, including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference this year showcased how our community is focused on driving discovery of new treatments for the millions of patients that are afflicted by neurological and psychiatric diseases. This endeavor presents very unique challenges, with many failures and amazing successes that were all showcased through panel discussions and in depth company presentations.

The conference featured keynotes on the current state of the neurotech industry, cutting edge company presentations, leading translational research projects and interactive panel discussions which covered a comprehensive selection of neurotech topics. Our 1-on-1 Partnering Service (powered by Brella) allowed delegates to connect with similar participants to advance their partnering & fundraising goals. Over 140 meetings were scheduled across the two conference days.

The feedback we have received from many of you, thus far, has been quite positive. Please continue to share your ideas with us so we can make Neurotech even more useful and relevant for you.

Save the date for 2020! The Neurotech Investing & Partnering Conference is returning to Boston, May 5-6, 2020 at the Renaissance Waterfront Hotel

Present your company’s device, drug, and/or therapy at next year’s event! For questions or suggestions about the conference and to submit a speaker proposal, contact the Neurotech team at info@neurotechpartnering.com

Thank you for your continued support of the Neurotech Investing and Partnering Conference!

Kindest Regards,
Carla Lema Tome, Conference Producer
and the Neurotech 2019 team


Eric Schaeffer, PhD
Senior Director of Neuroscience Innovation, Johnson & Johnson Innovation

Pierandrea Muglia, MD
Vice President & Head Neuroscience Discovery Medicine, UCB Pharma

Murali Gopalakrishnan, MBA, PhD
Senior Director & Global Head, Search & Evaluation Neuroscience


Laszlo Kiss, PhD
Executive Director, WRD / Principal, Pfizer Ventures

Nicholas Scarchilli
Director, Business Development, Biogen

Atsushi Hashimoto
Vice President, Business Development, Mitsubishi Tanabe Pharma


Attendee Demographics

Register Early for Maximum Savings